Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018
Effect of protein S on lipopolysaccharide-induced acute lung injury Source: Eur Respir J 2006; 28: Suppl. 50, 398s Year: 2006
Effect of tyrosine kinase inhibitors, imatinib and nilotinib, in murine lipopolysaccharide-induced acute lung injury during neutropenia recovery Source: Annual Congress 2013 –Experimental models in critical care Year: 2013
AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015
Effect of lipopolysaccharide (LPS) priming on Candida -induced acute lung injury (ALI) Source: Eur Respir J 2003; 22: Suppl. 45, 585s Year: 2003
Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006
Down-regulation of RIP140 can prevent LPS-induced inflammation and acute lung injury in mice via PPARγ Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015
Human protein C concentrate administration reduces inflammation and apoptosis in lung after experimental sepsis Source: Eur Respir J 2005; 26: Suppl. 49, 461s Year: 2005
Inhibition of lung inflammation by a protein epitope mimetic (PEM) neutrophil elastase inhibitor, POL6014, in a sub-chronic tobacco smoke (TS) model in mice Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013
Aminoguanidine attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of heat shock protein 47 and TGF-β1 expression Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008
Effects of S-nitroso-N-acetyl-penicillamine (SNAP) on inflammation, apoptosis and iNOS activity in an experimental model of acute lung injury Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015
Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
Erythropoietin (EPO) attenuates the immunohistochemical expression of autophagy antibodies in bleomycin (BLM), induced pulmonary fibrosis (PF) in rats Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib, naphthalene-induced acute pneumonitis in mice Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015
Altered expression of claudin 5 isotype modulates tight junctions permeability in experimental LPS-induced acute lung injury in mice Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013
Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment Source: Eur Respir J 2012; 40: 416-423 Year: 2012
Inhaled activated protein C protects mice from ventilator-induced lung injury Source: Annual Congress 2009 - Acute lung injury: biological mechanisms Year: 2009
Febrile-range hyperthermia (FRH) augments neutrophil acccumulation and enhances lung injury in a model of diffuse pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 719s Year: 2004
Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury Source: Eur Respir J 2009; 33: 1415-1428 Year: 2009
Heat shock protein 90 inhibitors block pulmonary fibrosis and dysfunction in HCl-exposed mice. Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis Year: 2017